156 related articles for article (PubMed ID: 34369844)
1. Drug discovery targeting p21-activated kinase 4 (PAK4): a patent review.
Wang H; Song P; Gao Y; Shen L; Xu H; Wang J; Cheng M
Expert Opin Ther Pat; 2021 Nov; 31(11):977-987. PubMed ID: 34369844
[No Abstract] [Full Text] [Related]
2. Strategy and validation of a structure-based method for the discovery of selective inhibitors of PAK isoforms and the evaluation of their anti-cancer activity.
Song PL; Wang G; Su Y; Wang HX; Wang J; Li F; Cheng MS
Bioorg Chem; 2019 Oct; 91():103168. PubMed ID: 31400553
[TBL] [Abstract][Full Text] [Related]
3. The discovery and the structural basis of an imidazo[4,5-b]pyridine-based p21-activated kinase 4 inhibitor.
Park JK; Kim S; Han YJ; Kim SH; Kang NS; Lee H; Park S
Bioorg Med Chem Lett; 2016 Jun; 26(11):2580-3. PubMed ID: 27117431
[TBL] [Abstract][Full Text] [Related]
4. Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors.
Hao C; Zhao F; Song H; Guo J; Li X; Jiang X; Huan R; Song S; Zhang Q; Wang R; Wang K; Pang Y; Liu T; Lu T; Huang W; Wang J; Lin B; He Z; Li H; Li F; Zhao D; Cheng M
J Med Chem; 2018 Jan; 61(1):265-285. PubMed ID: 29190083
[TBL] [Abstract][Full Text] [Related]
5. P21-activated kinase 4--not just one of the PAK.
Dart AE; Wells CM
Eur J Cell Biol; 2013; 92(4-5):129-38. PubMed ID: 23642861
[TBL] [Abstract][Full Text] [Related]
6. p21-Activated kinase inhibitors: a patent review.
Crawford JJ; Hoeflich KP; Rudolph J
Expert Opin Ther Pat; 2012 Mar; 22(3):293-310. PubMed ID: 22404134
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 2,4-diaminopyrimidine derivatives targeting p21-activated kinase 4: Biological evaluation and docking studies.
Qin Q; Wu T; Yin W; Sun Y; Zhang X; Wang R; Guo J; Zhao D; Cheng M
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000097. PubMed ID: 32627873
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors.
Song S; Li X; Guo J; Hao C; Feng Y; Guo B; Liu T; Zhang Q; Zhang Z; Li R; Wang J; Lin B; Li F; Zhao D; Cheng M
Org Biomol Chem; 2015 Mar; 13(12):3803-18. PubMed ID: 25705811
[TBL] [Abstract][Full Text] [Related]
9. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F
Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492
[TBL] [Abstract][Full Text] [Related]
10. Discovery and the structural basis of a novel p21-activated kinase 4 inhibitor.
Ryu BJ; Kim S; Min B; Kim KY; Lee JS; Park WJ; Lee H; Kim SH; Park S
Cancer Lett; 2014 Jul; 349(1):45-50. PubMed ID: 24704155
[TBL] [Abstract][Full Text] [Related]
11. Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy.
Hao C; Huang W; Li X; Guo J; Chen M; Yan Z; Wang K; Jiang X; Song S; Wang J; Zhao D; Li F; Cheng M
Eur J Med Chem; 2017 May; 131():1-13. PubMed ID: 28284095
[TBL] [Abstract][Full Text] [Related]
12. The role of PAK4 in the immune system and its potential implication in cancer immunotherapy.
Naїja A; Merhi M; Inchakalody V; Fernandes Q; Mestiri S; Prabhu KS; Uddin S; Dermime S
Cell Immunol; 2021 Sep; 367():104408. PubMed ID: 34246086
[TBL] [Abstract][Full Text] [Related]
13. The Cdc42 Effector Kinase PAK4 Localizes to Cell-Cell Junctions and Contributes to Establishing Cell Polarity.
Selamat W; Tay PL; Baskaran Y; Manser E
PLoS One; 2015; 10(6):e0129634. PubMed ID: 26068882
[TBL] [Abstract][Full Text] [Related]
14. Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.
Ramos-Álvarez I; Lee L; Jensen RT
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G490-G503. PubMed ID: 31984786
[TBL] [Abstract][Full Text] [Related]
15. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.
Shao YG; Ning K; Li F
World J Gastroenterol; 2016 Jan; 22(3):1224-35. PubMed ID: 26811660
[TBL] [Abstract][Full Text] [Related]
16. Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation.
Su Y; Song P; Wang H; Hu B; Wang J; Cheng MS
J Biomol Struct Dyn; 2020 Aug; 38(13):3825-3837. PubMed ID: 31490101
[TBL] [Abstract][Full Text] [Related]
17. Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study.
Guo J; Zhu M; Wu T; Hao C; Wang K; Yan Z; Huang W; Wang J; Zhao D; Cheng M
Bioorg Med Chem; 2017 Jul; 25(13):3500-3511. PubMed ID: 28502459
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4.
Li Z; Li X; Xu L; Tao Y; Yang C; Chen X; Fang F; Wu Y; Ding X; Zhao H; Li M; Qian G; Xu Y; Ren J; Du W; Wang J; Lu J; Hu S; Pan J
Oncol Rep; 2017 Nov; 38(5):2705-2716. PubMed ID: 29048629
[TBL] [Abstract][Full Text] [Related]
19. Kaempferol as a Potential PAK4 Inhibitor in Triple Negative Breast Cancer: Extra Precision Glide Docking and Free Energy Calculation.
Arowosegbe MA; Amusan OT; Adeola SA; Adu OB; Akinola IA; Ogungbe BF; Omotuyi OI; Saibu GM; Ogunleye AJ; Kanmodi RI; Lugbe NE; Ogunmola OJ; Ajayi DC; Ogun SO; Oyende FO; Bello AO; Ishola PG; Obasieke PE
Curr Drug Discov Technol; 2020; 17(5):682-695. PubMed ID: 31441728
[TBL] [Abstract][Full Text] [Related]
20. Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.
Fulciniti M; Martinez-Lopez J; Senapedis W; Oliva S; Lakshmi Bandi R; Amodio N; Xu Y; Szalat R; Gulla A; Samur MK; Roccaro A; Linares M; Cea M; Baloglu E; Argueta C; Landesman Y; Shacham S; Liu S; Schenone M; Wu SL; Karger B; Prabhala R; Anderson KC; Munshi NC
Blood; 2017 Apr; 129(16):2233-2245. PubMed ID: 28096095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
